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ABSTRACT
Introduction: The efficacy of bariatric surgery for
large-scale, long-term weight loss is well established.
However, many questions remain over the continual
benefits and cost-effectiveness of that weight loss for
overall health, particularly when accounting for
potential complications and adverse events of
surgery. Health research institutes in the UK and the
USA have called for high-quality longitudinal cohort
studies of patients undergoing bariatric surgery,
assessing outcomes such as surgical complications,
mortality, diabetes remission, microvascular
complications, cardiovascular events, mental health,
cost and healthcare use.
Methods and analysis: SurgiCal Obesity
Treatment Study (SCOTS) is a national, prospective,
observational, cohort study of patients undergoing
primary bariatric surgical procedures in Scotland.
This study aims to recruit 2000 patients and
conduct a follow-up for 10 years postbariatric
surgery using multiple data collection methods:
surgeon-recorded data, electronic health record
linkage, and patient-reported outcome measures.
Outcomes measured will include: mortality, weight
change, diabetes, surgical, cardiovascular, cancer,
behavioural, reproductive/urological and nutritional
variables. Healthcare utilisation and economic
productivity will be collected to inform cost-
effectiveness analysis.
Ethics and dissemination: The study has received
a favourable ethical opinion from the West of
Scotland Research Ethics committee. All publications
arising from this cohort study will be published in
open-access peer-reviewed journals. All SCOTS
investigators (all members of the research team at
every recruiting site) will have the ability to propose
research suggestions and potential publications using
SCOTS data; a publications committee will approve
all requests for use of SCOTS data and propose
writing committees and timelines. Lay-person
summaries of all research findings will be published
simultaneously on the SCOTS website (http://www.
scotsurgeystudy.org.uk).
INTRODUCTION
The efﬁcacy of bariatric surgery for
large-scale, long-term weight loss is well
established.1 However, many questions
remain over the continual beneﬁts of that
weight loss for overall health, particularly
when accounting for potential complications
of surgery. In 2009, Picot et al2 published a
systematic review and economic evaluation of
the clinical and cost-effectiveness of bariatric
surgery for obesity, funded by the UK’s
Strengths and limitations of this study
▪ The major advantage of SurgiCal Obesity
Treatment Study (SCOTS) is the availability of
high-quality health record data recorded in a stan-
dardised manner across Scotland.
▪ Inclusion of all state-funded and private hospitals
undertaking bariatric surgery ensures geograph-
ical representation.
▪ SCOTS will allow detailed follow-up of clinical,
surgical outcomes and changes in health status
after bariatric surgery, underpinned with a
detailed cost-effectiveness analysis based on real-
life care and treatment practices.
▪ The design of the study means that participants
will be able to be followed through record-linkage
for many decades, until death, at minimal add-
itional cost. All patients can be followed, therefore
removing any potential for bias from/to partici-
pant drop-out due to poor surgical outcome or ill
health.
▪ The major limitation of SCOTS is the relatively low
numbers of bariatric surgery procedures per-
formed in Scotland per head of population, and
the challenge of low volume centres compared
with international standards. However, the data
collection has been designed with this in mind to
ensure that surgeon and centre experience is cap-
tured, and this variety will allow surgical experi-
ence to be explored as an explanatory variable.
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National Institute for Health Research (NIHR) Health
Technology Assessment Programme (HTA). The conclu-
sion was that high-quality data were lacking and further
research was required, particularly large-scale cohort
studies to ascertain patient quality of life, late complica-
tions requiring reoperation, the effect of surgeon experi-
ence, duration of comorbidity remission and the full use
of health and care resources to allow comprehensive
cost-effectiveness analysis.
In May 2013, the USA National Institute for
Diabetes and Digestive and Kidney Diseases and the
National Heart, Lung and Blood Institute held a multi-
disciplinary workshop on the long-term outcomes of
bariatric surgery, and reached similar conclusions
regarding research priorities to that of Picot et al.3
The main areas highlighted as having signiﬁcant
knowledge gaps included the incidence of surgical
complications, overall mortality, duration of type 2 dia-
betes remission and microvascular complications,
cardiovascular events, mental health outcomes, malig-
nancies, fertility and fetal outcomes, and overall cost
and healthcare use. This workshop agreed that there
should be investment in high-quality, observational
studies, potentially utilising electronic health records
where available.
In response to the Picot systematic review, in 2010, UK
NIHR HTA issued an open call for research proposals
for a long-term longitudinal cohort study of patients
undergoing bariatric surgery in the UK, with a
minimum of 10 years follow-up. The outcomes were to
include quality of life, survival, weight, BMI, diabetes
and surgical complications. The SurgiCal Obesity
Treatment Study (SCOTS) was funded in 2011. This
paper describes the study design and outcomes.
OBJECTIVES
The overall objective of SCOTS is to establish the clinical
outcomes and adverse events of different bariatric surgi-
cal procedures, their impact on quality of life and nutri-
tional status, and the effect on comorbidities in the
short and long term in a cohort of over 2000 patients.
The speciﬁc objectives are to establish in a cohort of
obese patients who are undergoing bariatric surgery
▸ All-cause and cause-speciﬁc mortality over a mean of
10 years since bariatric surgery.
▸ Incidence of cardiovascular disease, cancer and diag-
nosis of diabetes over a mean of 10 years since baria-
tric surgery.
▸ Incidence of acute and chronic postoperative compli-
cations. Acute complications, deﬁned as up to
3 months postsurgery, will include surgical site infec-
tion; chronic complications will include revisional
surgery, plastic surgery and chronic pain.
▸ Change in health-related quality of life, anxiety and
depression over time, preoperatively and postopera-
tively, for a mean of 10 years from the date of baria-
tric surgery.
▸ The micronutrient and weight status preoperatively
and postoperatively for a mean of 10 years since baria-
tric surgery.
▸ The glycaemic control, lipids, blood pressure, medica-
tion prescription and rate of diabetes complications
(microalbuminuria and renal disease, retinopathy
and foot ulceration) in those that have pre-existing
diabetes or develop diabetes during a mean of
10 years of follow-up since bariatric surgery.
▸ Explanatory variables will be explored for each
outcome.
METHODS
Study design
SCOTS is a national, prospective, observational cohort
study of patients undergoing primary bariatric surgical
procedures in Scotland. A total of 2000 patients will be
recruited over a 5-year period from 2014 to 2019, and
will be followed for a mean follow-up period of 10 years
postsurgery.
Participant and centre eligibility
Patients scheduled to undergo bariatric surgery at any
state-funded or private hospital in Scotland will be eli-
gible for entry into the cohort. Currently, 10 state-
funded and 4 private hospitals across Scotland provide
bariatric surgery, and are thus eligible to participate.
For the purposes of SCOTS, a bariatric surgical pro-
cedure is deﬁned as ‘any surgical intervention which has
the primary purpose of large-scale weight loss in a
patient who is obese’. Eligible procedures include
Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy
(SG) and laparoscopic adjustable gastric banding
(LAGB). The inclusion of emerging techniques in this
deﬁnition will be considered by the Steering Committee
throughout the duration of the cohort. At current rates
for Scotland, it is anticipated that this may result in 60%
of participants having SG, 30% LAGB, and 20% RYGB,
but changing trends in the type of surgery offered may
alter these predicted patterns.
SCOTS has received a favourable ethical opinion from
the West of Scotland Research Ethics Committee, and
full management approval at each hospital site.
Outcomes
The outcomes to be measured include mortality, weight,
diabetes, surgical complications, cardiovascular, cancer,
behavioural, reproductive/urological and nutritional
outcomes. Other healthcare resource use of variables
will be collected to inform a cost-effectiveness analysis.
Outcomes are summarised in table 1.
Data collection
Data will be obtained from three main sources: the sur-
gical team, patients, and from electronic health records
(table 2). For some outcomes, multiple sources will be
used to collect similar data to ensure overall
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completeness of the data set (eg, revisional surgery will
be collated from clinical teams, self-reported by patients
and from electronic health records; fractures will be
reported through either hospital and emergency depart-
ment admissions, or through radiology reports).
Where possible, deﬁnitions and data sources have
been kept consistent with the UK National Bariatric
Surgery Register4 and the NIH-funded Longitudinal
Assessment of Bariatric Surgery5 to allow comparison
and meta-analysis of outcomes.
Recruitment procedures and consent
Patients are approached about the study at least 4 weeks
prior to their primary bariatric surgical procedure. This
is undertaken by either the clinical bariatric surgery
team or by a research nurse in preoperative assessment
clinics. Patients are shown an 8 min information ﬁlm
and provided with an information booklet explaining
the SCOTS. Individual participant consent is obtained
on a subsequent clinical visit. Informed consent is
sought at three levels, for (1) access to medical records
Table 1 Surgical obesity treatment study outcomes
Outcome category Specific outcomes
Mortality 30 day, 1 year and 10 year mortality; all-cause and cause-specific
Weight Change in weight/body mass index
Surgical Incidence of surgical complications 1 year and 10 years postoperatively
Hospital length of stay/rate of readmission
Incidence of surgical site infection
Postoperative pain
Rate of reoperation
Rate of revisional procedures
Rate of body-contouring surgery
Incidence of excess skin affecting daily life
Change in gastrointestinal symptoms
Cardiovascular Incidence of fatal and non-fatal cardiovascular events
Incidence of fatal and non-fatal coronary heart disease
Cardiovascular medication prescription
Diabetes Incidence of type 2 diabetes
Change in glycaemic control
Change in blood lipid concentration
Change in blood pressure
Change in estimated glomerular filtration rate and microalbuminuria
Incidence of retinopathy
Incidence of amputation
Incidence of chronic kidney disease
Diabetes medication prescription
Cancer Incidence of all and specific cancers
Behavioural Change in prevalence/incidence of depression and anxiety
Change in health-related quality of life
Change in rate of alcohol use disorder
Change in smoking status
Change in physical activity levels
Change in fat, fibre and calcium intake
Life orientation (optimism)
Reproductive/urological Change in menstrual cycle/abnormalities
Incidence of pregnancy and fetal outcome
Change in prevalence of incontinence
Change in prevalence of prostatic symptoms
Change in rate of erectile dysfunction
Nutritional Incidence of micronutrient deficiency
Prescription of multivitamins and nutritional supplements
Economic Cost of presurgical and postsurgical care pathways
Healthcare utilisation
Change in receipt of Social Security benefits
Change in employment status
Change in education
Sickness absence from work/study
Change of use of aids and specialist equipment (eg, walking frame or stair lift)
Social care requirements
Fractures Incidence of fractures by site
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and linkage of their electronic health records, (2) postal
questionnaires preoperatively and postoperatively and
(3) contact for future studies. Each level of consent is
dependent on the previous level, for example, postal (or
electronic) questionnaires are not sent without consent
to link electronic health records.
Table 2 Surgical obesity treatment study data collection
Data collection Type Questionnaire
Surgical data
Primary procedure Surgeon
Procedure
Operative details (including band type, staple type, approach, dissection,
biliopancreatic limb length)
Presurgical intervention (including balloon or endobarrier)
Patient weight day of operation
American Society of Anesthesiologists (ASA) grade
Operation performed by surgeon in training
Perioperative blood transfusion
Reoperations Reoperation (detail as per primary procedure)
Reason for reoperation
Surgical experience Surgeon experience (baseline, updated annually)
Patient-reported outcome measures
Demographics ID, sex, age
Marital status
Ethnicity
Education
Occupation
Medical history Medical history8
Weight history9
Family history (diabetes, coronary heart disease (CHD))
Family history (weight)
Quality of life—Health
related
SF1210
EQ5D 5 L11
Patient Health Questionnaire (PHQ9)12
Generalised Anxiety Disorder (GAD7)13
Impact of weight Impact of Weight on Quality of Life (IWQOL)-Lite14
Reproductive health (female)5
Erectile dysfunction—Massachusetts Male Aging Study: Single question
assessment (male)15
International Prostate Symptom Score16
International Consultation on Incontinence Questionnaire Urinary Incontinence
Short Form17
Modified Reflux questionnaire18
Lifestyle Smoking
Alcohol Use Disorders Identification Test: Self-Report Version19
International Physical Activity Questionnaire short last 7 days self-administered
format20
Dietary Fat and Fibre intake
Dietary Intervention in Primary Care (DINE)21
Personal outlook Life orientation test (revised)22
Expectations of surgery—Goals and Relative Weights Questionnaire23
Surgical recovery Postoperative pain
Surgical site infection24
Skin excess
Body contouring surgery25
Healthcare usage Outpatient care26
Contacts with other health and social care professionals
Devices and specialist equipment27
Benefits
Multivitamins and supplements use
Continued
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Surgical data
In order to encourage site participation and maintain
interest in the study, data from the surgical clinical
team is collected using a speciﬁcally designed, web-
based, clinical information system which has a number
of features of use to the clinical teams. At ﬁrst log-in,
the system records basic surgical data, including
surgeon experience, local operative procedures per-
formed at that site including the standard approach for
each procedure performed by that surgeon (eg, make
of staple or bands used). Details of consented indivi-
duals are entered by the central study centre, and the
details of each patient are visible to that local clinical
team allowing them to enter further preoperative and
surgical details. This is kept simple by allowing some
modiﬁcation to the standard surgical details stored.
SCOTS data collection system allows weight and band
adjustments at follow-up visits to be recorded, as well as
details of, and indications for, revisional surgery. If revi-
sional surgery is being performed at another site, the
patient’s record can be identiﬁed on the system. A
number of templates exist for clinical letters, patient
reports and clinical notes which populate with details
from the system and output as a portable document
format (pdf) ﬁle for entry into hospital letters and
records.
Patient-reported outcome measures
Participants are asked to complete a suite of question-
naires at a number of time points throughout the study:
preoperatively and 1 month, 6 months, 1, 2, 3, 5, 7 and
10 years postoperatively. Questionnaires were developed
in conjunction with patient involvement and were
piloted (described below). Final questionnaires consist
of validated scales covering a wide range of outcome
measures. Participants have the option of completing
these via a web-based system or on paper by post. They
receive up to two reminders for each questionnaire. The
full questionnaire takes around 1 h to complete, and
start and ﬁnish dates are recorded to allow them to be
completed over several days.
Questionnaires at all time points include weight,
marital status, education, employment, general and
obesity-speciﬁc quality of life, anxiety, depression, repro-
ductive health, urological health, gastrointestinal symp-
toms, smoking, alcohol use, physical activity, diet,
healthcare utilisation, social security and nutritional sup-
plements. Baseline preoperative questionnaires include
demographics, medical history, family history, weight
history and expectations of surgery. Postoperative ques-
tionnaires include surgical recovery, pain intensity, surgi-
cal site infection, skin excess and plastic surgery.
Electronic health records
Scotland is fortunate to have excellent electronic
health records. All patient healthcare interactions in
Scotland are recorded by use of a single patient ID
number. IT systems are common across all 14 health
board areas, and a single government-funded depart-
ment (Information Services Division) collates informa-
tion for research purposes. This has allowed Scotland to
become a leader in research using routine health
records, and these systems are being utilised for
follow-up in SCOTS.
Participants in SCOTS will be followed using multiple
existing Scottish health record data sets: Scottish
Morbidity Records—general acute/inpatient and day
case (SMR 01), maternity inpatient and day case (SMR
02), and mental health inpatient and day case (SMR 04)
data sets; National Records of Scotland Death Records;
Scottish Cancer Registry; Scottish Care Information dia-
betes data set (SCI-Diabetes); Scottish Care Information
Store (SCI-Store) diagnostic data set and the prescribing
information system dataset.
Evidence of quality assurance for electronic health
record data sets in Scotland is very high: an assessment
Table 2 Continued
Data collection Type Questionnaire
Electronic health
records
Hospital admissions Diagnosis, length of stay, intensive/high dependency, in-hospital mortality
Scottish Morbidity Record 01
Maternity Inpatient and day case including birth weight, gestational age, mode of delivery,
induction, pregnancy outcome and neonatal care
Scottish Morbidity Record 02/Scottish Birth Record
Psychiatric Inpatient care records—including diagnosis, treatment, length of stay
Scottish Morbidity Record 04
Malignancy Site, histology, stage, grade, treatment
Scottish Cancer Registry
Mortality National Records of Scotland Death Records
Diagnostic tests Biochemistry, haematology, radiology, pathology and microbiology results
Scottish Care Information—Store
Diabetes Including date of diagnosis, type, treatment, retinal and foot screening
Scottish Care Information—diabetes
Medications Type and adherence—encashed prescriptions
Prescribing Information System
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of 2010/2011 data by comparison with local hospital
case records showed an overall high degree of accuracy.
For conditions of interest, this included accuracy of
97.3% for ischaemic heart disease, 99.3% for fractures,
98.2% for myocardial infarction and 98.4% for upper
gastrointestinal endoscopy.6 Diabetes records are derived
from all hospitals in Scotland and all of approximately
1000 primary care centres (except 5), which are down-
loaded to SCI-Diabetes on a daily basis. This dataset
represents over 99% of people with diagnosed diabetes
in Scotland.
Treatment pathways
Every site completes an annual survey to detail their
current preoperative and postoperative care pathways.
This includes how patients enter the surgical pathway
(eg, direct or self-referral or via a non-surgical weight
management programme), any presurgical requirements
for weight loss and the standard numbers of appoint-
ments with dieticians, psychologists, surgeons and physi-
cians that each patient receives. This information will
allow outcomes from high-contact and low-contact pre-
surgical and postsurgical care pathways to be compared.
Health economics
Health economist involvement in the design and devel-
opment of the study has ensured that all relevant health-
care resource use data will be captured. Cost analysis
will involve comparison of preoperative and post-
operative care pathways at each site, and will include esti-
mates of the costs of immediate (30 day) postoperative
complications.
Surgical learning curve
The effect of the surgical learning curve on patient
outcome is now well recognised.7 In order to account
for this within analyses, surgeons will be asked to record
date of completion of postgraduate surgical training and
volume of bariatric surgery procedures performed
(total, last 1 and 5 years). Total numbers of bariatric pro-
cedures (primary and revisional) performed by each
individual surgeon in the previous year are also
requested annually.
Adverse outcome reporting
Given the duration of this epidemiological study, there is
a possibility that higher than expected adverse event rates
may be detected, such as surgical site infection or 30-day
surgical mortality. An adverse outcome plan has been
agreed by the Steering Committee, and all participating
surgeons have approved this plan. In preparation for
each peer-reviewed publication, the study statisticians will
generate reports to assess variability in outcomes between
study sites, but these will be anonymised. No statistical
analysis will be undertaken at individual surgeon level.
Rates will be presented for all sites using funnel plots,
with adjustment for case-mix, to identify sites that have
outcome rates signiﬁcantly above or below what would be
expected given patient characteristics (which will be pre-
deﬁned in the statistical analysis plan). If a particular site
is identiﬁed by the SCOTS team as having a potentially
poorer outcome than expected, a letter will be sent from
the Chief Investigator to the Principal Investigator and
the Medical Director covering that site. An individual
report will be prepared for that study site, summarising
key data for that site, and including copies of the funnel
plots from the main report, with the data point for that
study site highlighted. Outcomes which will be consid-
ered eligible for assessment include rates of mortality,
pulmonary thromboembolic disease, cardiovascular
disease at 1 year, reoperations, surgical site infections,
and nutritional deﬁciencies.
Reference populations/comparator groups
Collection of similar data from a non-surgical comparator
group is not funded within the SCOTS, however, we have
access to a number of possible reference populations.
Electronic diabetes health record data sets allow an
anonymous comparator group, matched for key demo-
graphics, to be created with prospective follow-up of dia-
betes care and complications compared to those with
diabetes who had bariatric surgery. Also, several of the
non-surgical weight management services within
Scotland have detailed patient records again allowing the
formation of anonymous comparator groups. Large
cohorts, such as UK Biobank, also provide reference
populations with prospective outcomes. In time, we hope
to develop a similar cohort of patients undergoing life-
style weight management with a comparable collection of
baseline data, including psychological and mental health
questionnaires, to help account for any biases within a
self-selecting bariatric surgery population.
Patient involvement
We sought to form a patient public involvement (PPI)
group to allow patient representation and input in the
design of the study; public and patient involvement is
encouraged by UK research councils, and mandatory for
NIHR-funded research. A small focus group was formed
comprising ﬁve patients who had previously undergone
bariatric surgery in either the state-funded or private
sector. The SCOTS PPI group has been consulted over a
number of topics including: the information provided to
patients about the study (patient information sheets,
invitation letters and web site), content and design of
electronic and paper patient-reported questionnaires,
communication throughout the study, such as newslet-
ters and reminder letters, and the need for incentives to
take part and complete questionnaires. The focus group
has met twice, each meeting lasting 3–4 h; participants
have also been contacted by email periodically with add-
itional questions.
Development of patient questionnaires
Piloting of patient questionnaires was undertaken
during the development phase of the study. Some
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speciﬁc questions were considered by researchers to be
of a sensitive nature (eg, sexual function, continence).
However, these were not considered ‘sensitive’ by the
SCOTS PPI focus group. Rather, items relating to diet,
exercise and welfare beneﬁts were considered to be par-
ticularly sensitive because they felt participants may feel
‘judged’. To counter this, the PPI group requested the
inclusion of a short explanatory sentence on why sec-
tions of questions were included. The group also identi-
ﬁed important topics that were not included within the
original question set, in particular, the inclusion of the
need for dental work after bariatric surgery. Incentives
were not felt to be necessary and were discounted in
favour of a six monthly newsletter to include study pro-
gress, ﬁndings and words of continued thanks for
participation.
DISSEMINATION PLANS
All publications arising from this cohort will be pub-
lished in open-access peer-reviewed journals. All
SCOTS investigators (all members of the research team
at every recruiting site) will have the ability to propose
research suggestions and potential publications using
SCOTS data; a publications committee will approve all
requests for use of SCOTS data and propose writing
committees and timelines. Lay-person summaries of all
research ﬁndings will be published simultaneously on
the SCOTS website (http://www.scotsurgeystudy.org.
uk). As is now recognised practice, we plan to make
our data fully available for use in an anonymous form
by other researchers at the end of the currently funded
time period of this study (2027). Patient consent proce-
dures cover the sharing of data for future research by
external researchers. We will follow the NHS code of
Practice on Protecting Patient Conﬁdentiality issued by
NHS Scotland. We will require a written request/pro-
posal for data to be made to our publications commit-
tee who will need to be satisﬁed that all ethical
approvals are in place and that funds are available to
cover any costs of collating the necessary data. Regular
reports of progress with the research will be required.
The collaboration with the SCOTS study group should
be acknowledged in the manuscript, normally by
authorship stating the research workers ‘on behalf of
the SCOTS group’.
ADVANTAGES AND LIMITATIONS
The major advantage of SCOTS is the availability of
high-quality health record data recorded in a standar-
dised manner across Scotland. Inclusion of all state-
funded and private hospitals undertaking bariatric
surgery ensures geographical representation.
SCOTS will allow detailed follow-up of clinical, surgical
outcomes and changes in health status after bariatric
surgery, underpinned with a detailed cost-effectiveness
analysis based on real-life care and treatment practices.
The design of the study means that participants will be
able to be followed through record-linkage for many
decades, until death, at minimal additional cost. All
patients can be followed, therefore removing any poten-
tial for bias from to participant dropout due to poor sur-
gical outcome or ill health.
The major limitation of SCOTS is the relatively low
numbers of bariatric surgery procedures performed in
Scotland per head of population, and the challenge of
low-volume centres compared with international stan-
dards. As a consequence, RYGB is the least commonly
performed operation. These factors will be taken into
account during analysis and compared with results from
other studies. However, the data collection has been
designed with this in mind to ensure that surgeon and
centre experience is captured, and this variety will allow
surgical experience to be explored as an explanatory
variable.
CONCLUSIONS
SCOTS is the ﬁrst national epidemiological study investi-
gating long-term outcomes after bariatric surgery. This
large data set will be one of the most detailed prospect-
ive cohort studies of bariatric surgery to date, made pos-
sible through linkage to high-quality, country-wide,
electronic health records. SCOTS will assess important
clinical, surgical and patient-reported outcomes over a
10-year period, including the incidence of, and risk
factors for, surgical complications, overall mortality, dia-
betes remission, diabetes, microvascular complications,
cardiovascular events, mental health, cancers, genito-
urinary and reproductive outcomes. This study will add
substantially to the evidence base for the long-term
effectiveness and cost-effectiveness of bariatric surgery
outcomes.
International implications
No single study should be used to generate evidence for
a commonly performed group of procedures that are
the most effective treatment for a condition that effects
∼28% of people in the USA, and ∼22% of Europeans.
We have developed a data set to allow important ques-
tions about bariatric surgery to be answered. However,
bariatric surgery in Scotland is performed in low
numbers compared with other countries; while we have
excellent electronic data linkage, overall numbers of
patients are low. Other sites may not have access to
similar linked data, but do have higher numbers of
patients. We would welcome the opportunity to collabor-
ate with sites in other countries to compare patient-
reported data, and electronic health record data when
available, to validate the generalisability of our detailed
clinical outcome data for other populations.
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